Diferencia entre revisiones de «Harbor:Sepsis antibiotics»

Línea 51: Línea 51:


*Mild HAP/HCAP no recent antibiotic exposure:  
*Mild HAP/HCAP no recent antibiotic exposure:  
**'''[[Cefepime]] '''2g IV Q8H +/- '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]'''  
**'''[[Cefepime]] '''1g IV Q8H +/- '''[[Clindamycin]] '''600mg IV '''OR''' '''[[Metronidazole]]''' if risk of aspiration
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
*Moderate HAP/HCAP or necrotizing [[pneumonia]]:  
**Add '''[[Vancomycin]] '''for [[MRSA]]
**Add '''[[Vancomycin]] '''for [[MRSA]]

Revisión del 20:38 21 feb 2019

Unknown Source[1]

Pneumonia

Community Acquired Pneumonia (CAP)

MCC by S. pneumoniae. In young must cover for mycoplasma and other atypicals. See Pneumonia (Pathogens)

Treatment based on Pneumonia (Port Score)

Healthcare Associated pneumonia (HCAP) + Hospital Associated pneumonia (HAP)

HAP occurs if patient develops pneumonia 2-3 days after hospitalization. HCAP occus in non-hospitalized patient with extensive healthcare contact.

Abdominal/Pelvic

Urosepsis

Meningitis (Nl/Community)

Meningitis (Nl/Post neurosurgical)

Meningitis (Immunocomp)

(Cirrhosis, EtoH, age > 65, steroids, HIV)

Necrotizing Soft-tissue Infection

Neutropenic Fever

See Also

Harbor:Antibiotics by diagnosis

See also Harbor: Sepsis core measures
Initial Antibiotics in Sepsis (Main)

References

  1. Form v2011.09.15